<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="t0005" position="float">
 <label>Table 1</label>
 <caption>
  <p>Passive transfer of immune sera to AG129 mice and ZIKV challenge study design. Groups of AG129 mice receiving different passive transfer inoculum or control (
   <italic>n</italic> = 5 per group, male and female).
  </p>
 </caption>
 <alt-text id="al0035">Table 1</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="2">Group</th>
    <th>Passive transfer inoculum
     <xref rid="tf0005" ref-type="table-fn">a</xref>
     <hr/>
    </th>
    <th colspan="5">Study time points
     <hr/>
    </th>
   </tr>
   <tr>
    <th>(0 h)</th>
    <th>1 h</th>
    <th>12 h</th>
    <th>2 days</th>
    <th>4 days</th>
    <th>18 days</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>1</td>
    <td>VLP serum</td>
    <td rowspan="8">ZIKV challenge
     <xref rid="tf0015" ref-type="table-fn">c</xref>
    </td>
    <td rowspan="8">nAb
     <xref rid="tf0020" ref-type="table-fn">d</xref>
    </td>
    <td rowspan="8">Viral RNA
     <xref rid="tf0025" ref-type="table-fn">e</xref>
    </td>
    <td rowspan="8">Viral RNA
     <xref rid="tf0025" ref-type="table-fn">e</xref>
    </td>
    <td rowspan="8">nAb
     <xref rid="tf0020" ref-type="table-fn">d</xref>
    </td>
   </tr>
   <tr>
    <td>2</td>
    <td>VLP serum (1:5)</td>
   </tr>
   <tr>
    <td>3</td>
    <td>VLP + alum serum</td>
   </tr>
   <tr>
    <td>4</td>
    <td>VLP + alum serum (1:5)</td>
   </tr>
   <tr>
    <td>5</td>
    <td>Alum only serum</td>
   </tr>
   <tr>
    <td>6</td>
    <td>Naïve (no serum)</td>
   </tr>
   <tr>
    <td>7</td>
    <td>Untreated (no serum, no ZIKV
     <xref rid="tf0010" ref-type="table-fn">b</xref>)
    </td>
   </tr>
   <tr>
    <td>8</td>
    <td>Positive control ZKA190 mAb
     <xref rid="tf0030" ref-type="table-fn">f</xref>
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>Abbreviations: Alum, aluminum hydroxide adjuvant; ZIKV, Zika virus; nAb, neutralizing antibody</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tf0005">
   <label>a</label>
   <p id="np0005">Immune serum (250 μL) delivered by intravenous tail vein injection.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tf0010">
   <label>b</label>
   <p id="np0010">The untreated group was not challenged with ZIKV.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tf0015">
   <label>c</label>
   <p id="np0015">1000 FFU of ZIKV strain Nica 2-16 injection into foot pad.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tf0020">
   <label>d</label>
   <p id="np0020">Bleeds for serum were taken to measure nAb.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tf0025">
   <label>e</label>
   <p id="np0025">Bleeds for serum were taken to measure viral genome copies by RT-qPCR.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tf0030">
   <label>f</label>
   <p id="np0030">ZKA190 mAb transferred was 1 mg/kg in 250 μL.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
